Dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim) capsules have received tier 2 formulary status with 2 key pharmacy benefit managers.
Dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim) capsules have received tier 2 formulary status with 2 key pharmacy benefit managers (PBMs). Pradaxa was approved in October 2010 to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
The addition of Pradaxa to CVS Caremark (Commercial Preferred Drug List) and Medco (Commercial Preferred and Part D Drug Lists) formularies will offer NVAF patients increased access to Pradaxa.
“The Pradaxa preferred formulary status change is important since this novel agent for treatment of NVAF is now available at the lowest branded co-pay on formularies that insure about 35% of NVAF patients,” said Formulary Editorial Advisor Robert A. Quercia, MS, RPh, medical editor, Department of Pharmacy Services, University of Connecticut/Hartford Hospital, Evidence-based Practice Center, Hartford, Conn.
In the RE-LY trial, Pradaxa 150-mg capsules taken twice daily reduced the incidence of stroke and systemic embolism by 35% beyond the reduction achieved with warfarin, which was dosed to a target international normalized ratio (INR) of 2.0 to 3.0. The effects of Pradaxa compared to warfarin were more apparent in patients with lower levels of INR control.
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More